But for practitioners, this landscape is far more nuanced
It is intermediate between peptide chemistry and small-molecule medicinal chemistry
This is a welcome development, as it will increase access to tirzepatide for many people, said Dr Anoop Misra, chairman of Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases, and Endocrinology
(For more about Thymosin Beta 4 and other therapeutic peptides, see my blog post, The Healing and Rejuvenating Power of Therapeutic Peptides.) This combination of BPC-157 and Thymosin Beta 4 seems to provide even greater benefit to my patients
Salemme V, et al
The GLP-1 RA monitoring report describes more detailed information about the overall population of patients being prescribed these medications (including demographics and comorbidities), and the proportion and characteristics of patients who filled a GLP-1 RA prescription over time using dispenses